Theramex
Theramex is a pharmaceutical company based in London which produces women's health products focusing on contraception, fertility, menopause and osteoporosis.
It was established in 2018 with the acquisition of some of the assets of Teva Active Pharmaceutical Ingredients relating to Theramex Laboratories, a pharmaceutical company which was based in Monaco. Brands include Ovaleap, Zoely, Seasonique, Actonel, Estreva and Lutenyl.
It made an agreement with TherapeuticsMD in 2019 for exclusive licensing and supply rights to Bijuva and Imvexxy outside of the USA, Canada and Israel for which it paid a license fee of $15.5 million.
In 2021, Theramex launched Livogiva, Lundeos (Osteoporosis) and Bijuva (Menopause). That same year Theramex entered Consumer Healthcare Market with Femarelle, a non-hormonal option to treat menopause symptoms.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Livogiva | Teriparatide | 2020-08-27 | 2025 | |
| Ovaleap | Follitropin alfa | 2013-09-27 | ||
| Zoely | Estradiol, Nomegestrol | 2011-07-26 | 2024-2037 | |
| Yselty | Linzagolix choline | 2022-06-14 | ||
| Eladynos | Abaloparatide | 2022-12-12 | 2027-2040 |
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use